JPWO2022249942A1 - - Google Patents
Info
- Publication number
- JPWO2022249942A1 JPWO2022249942A1 JP2023523431A JP2023523431A JPWO2022249942A1 JP WO2022249942 A1 JPWO2022249942 A1 JP WO2022249942A1 JP 2023523431 A JP2023523431 A JP 2023523431A JP 2023523431 A JP2023523431 A JP 2023523431A JP WO2022249942 A1 JPWO2022249942 A1 JP WO2022249942A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024004935A JP2024032794A (ja) | 2021-05-24 | 2024-01-17 | 網膜の神経細胞の保護剤 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021086920 | 2021-05-24 | ||
| JP2021086920 | 2021-05-24 | ||
| JP2021172191 | 2021-10-21 | ||
| JP2021172191 | 2021-10-21 | ||
| PCT/JP2022/020635 WO2022249942A1 (ja) | 2021-05-24 | 2022-05-18 | 網膜の神経細胞の保護剤 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024004935A Division JP2024032794A (ja) | 2021-05-24 | 2024-01-17 | 網膜の神経細胞の保護剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2022249942A1 true JPWO2022249942A1 (https=) | 2022-12-01 |
| JPWO2022249942A5 JPWO2022249942A5 (https=) | 2023-12-11 |
| JP7427308B2 JP7427308B2 (ja) | 2024-02-05 |
Family
ID=84230063
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023523431A Active JP7427308B2 (ja) | 2021-05-24 | 2022-05-18 | 網膜の神経細胞の保護剤 |
| JP2024004935A Pending JP2024032794A (ja) | 2021-05-24 | 2024-01-17 | 網膜の神経細胞の保護剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024004935A Pending JP2024032794A (ja) | 2021-05-24 | 2024-01-17 | 網膜の神経細胞の保護剤 |
Country Status (3)
| Country | Link |
|---|---|
| JP (2) | JP7427308B2 (https=) |
| TW (1) | TWI901889B (https=) |
| WO (1) | WO2022249942A1 (https=) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008122032A2 (en) * | 2007-04-02 | 2008-10-09 | Benjamin Rubin | Treatment method for mmp-implicated pathologies |
| JP2016540827A (ja) * | 2013-11-06 | 2016-12-28 | ラプター ファーマシューティカルズ インコーポレイテッド | ミトコンドリア疾患を治療するためのシステアミン及びその誘導体の使用 |
-
2022
- 2022-05-18 JP JP2023523431A patent/JP7427308B2/ja active Active
- 2022-05-18 WO PCT/JP2022/020635 patent/WO2022249942A1/ja not_active Ceased
- 2022-05-23 TW TW111119134A patent/TWI901889B/zh active
-
2024
- 2024-01-17 JP JP2024004935A patent/JP2024032794A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008122032A2 (en) * | 2007-04-02 | 2008-10-09 | Benjamin Rubin | Treatment method for mmp-implicated pathologies |
| JP2016540827A (ja) * | 2013-11-06 | 2016-12-28 | ラプター ファーマシューティカルズ インコーポレイテッド | ミトコンドリア疾患を治療するためのシステアミン及びその誘導体の使用 |
Non-Patent Citations (5)
| Title |
|---|
| D'ONOFRIO, P. M. ET. AL.: "MMP Inhibition Preserves Integrin Ligation and FAK Activation to Induce Survival and Regeneration in", IOVS, vol. 60, no. 2, JPN6022028393, 2019, pages 634 - 649, ISSN: 0005228113 * |
| KUROSE, T. ET AL.: "Neuroprotective Effect of a Dietary Supplement against Glutamate-induced Excitotoxicity in Retina", INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, vol. 12, no. 8, JPN6022028399, 2019, pages 1231 - 1237, ISSN: 0005228117 * |
| MAHER, P. ET AL.: "A Novel Approach to Enhancing Cellular Glutathione Levels", JOURNAL OF NEUROCHEMISTRY, vol. 107, JPN6022028398, 2008, pages 690 - 700, ISSN: 0005228116 * |
| PAUL, B.D. ET AL.: "Therapeucit Applications of Cyeteamine and Cystamine in Neurodegenerative and Neuropsychiatric Disea", FRONTIERS IN NEUROLOGY, vol. Vol.10, Article 1315, JPN6022028396, 2019, pages 1 - 9, ISSN: 0005228115 * |
| SUN, M. ET AL.: "Down-Regulation of Matrix Metalloproteinase-9 by Pyrrolidine Dithiocarbamate Prevented Retinal Gangl", CURRENT EYE RESEARCH, vol. 36, no. 11, JPN6022028394, 2011, pages 1053 - 1063, ISSN: 0005228114 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024032794A (ja) | 2024-03-12 |
| JP7427308B2 (ja) | 2024-02-05 |
| TWI901889B (zh) | 2025-10-21 |
| WO2022249942A1 (ja) | 2022-12-01 |
| TW202312986A (zh) | 2023-04-01 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231028 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20231028 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20231028 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20231226 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240117 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7427308 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |